André Lin Ouédraogo1, Julie Zhang2,3, Halidou Tinto4, Innocent Valéa4, Edward A Wenger5. 1. Institute for Disease Modeling, Bill and Melinda Gates Foundation, 500 5th Ave N, Seattle, WA, 98109, USA. aouedraogo@idmod.org. 2. Department of Mathematics and Statistics, University of Washington, Seattle, WA, USA. 3. Department of Statistics, Stanford University, Palo Alto, CA, USA. 4. Institut de Recherche en Sciences de la Santé, Clinical Research Unit of Nanoro, Nanoro, Burkina Faso. 5. Institute for Disease Modeling, Bill and Melinda Gates Foundation, 500 5th Ave N, Seattle, WA, 98109, USA.
Abstract
BACKGROUND: Malaria incidence has plateaued in Sub-Saharan Africa despite Seasonal Malaria Chemoprevention's (SMC) introduction. Community health workers (CHW) use a door-to-door delivery strategy to treat children with SMC drugs, but for SMC to be as effective as in clinical trials, coverage must be high over successive seasons. METHODS: We developed and used a microplanning model that utilizes population raster to estimate population size, generates optimal households visit itinerary, and quantifies SMC coverage based on CHWs' time investment for treatment and walking. CHWs' performance under current SMC deployment mode was assessed using CHWs' tracking data and compared to microplanning in villages with varying demographics and geographies. RESULTS: Estimates showed that microplanning significantly reduces CHWs' walking distance by 25%, increases the number of visited households by 36% (p < 0.001) and increases SMC coverage by 21% from 37.3% under current SMC deployment mode up to 58.3% under microplanning (p < 0.001). Optimal visit itinerary alone increased SMC coverage up to 100% in small villages whereas in larger or hard-to-reach villages, filling the gap additionally needed an optimization of the CHW ratio. CONCLUSION: We estimate that for a pair of CHWs, the daily optimal number of visited children (assuming 8.5mn spent per child) and walking distance should not exceed 45 (95% CI 27-62) and 5 km (95% CI 3.2-6.2) respectively. Our work contributes to extend SMC coverage by 21-63% and may have broader applicability for other community health programs.
BACKGROUND: Malaria incidence has plateaued in Sub-Saharan Africa despite Seasonal Malaria Chemoprevention's (SMC) introduction. Community health workers (CHW) use a door-to-door delivery strategy to treat children with SMC drugs, but for SMC to be as effective as in clinical trials, coverage must be high over successive seasons. METHODS: We developed and used a microplanning model that utilizes population raster to estimate population size, generates optimal households visit itinerary, and quantifies SMC coverage based on CHWs' time investment for treatment and walking. CHWs' performance under current SMC deployment mode was assessed using CHWs' tracking data and compared to microplanning in villages with varying demographics and geographies. RESULTS: Estimates showed that microplanning significantly reduces CHWs' walking distance by 25%, increases the number of visited households by 36% (p < 0.001) and increases SMC coverage by 21% from 37.3% under current SMC deployment mode up to 58.3% under microplanning (p < 0.001). Optimal visit itinerary alone increased SMC coverage up to 100% in small villages whereas in larger or hard-to-reach villages, filling the gap additionally needed an optimization of the CHW ratio. CONCLUSION: We estimate that for a pair of CHWs, the daily optimal number of visited children (assuming 8.5mn spent per child) and walking distance should not exceed 45 (95% CI 27-62) and 5 km (95% CI 3.2-6.2) respectively. Our work contributes to extend SMC coverage by 21-63% and may have broader applicability for other community health programs.
Entities:
Keywords:
Burkina Faso; CHW; Community health worker; Door-to-door; Malaria; Microplanning; Model; SMC; Satellite imagery; Seasonal malaria chemoprevention
Authors: Gerard C Kelly; Chang Moh Seng; Wesley Donald; George Taleo; Johnny Nausien; Willie Batarii; Harry Iata; Marcel Tanner; Lasse S Vestergaard; Archie C A Clements Journal: Geospat Health Date: 2011-11 Impact factor: 1.212
Authors: Karim Derra; Eli Rouamba; Adama Kazienga; Sayouba Ouedraogo; Marc C Tahita; Hermann Sorgho; Innocent Valea; Halidou Tinto Journal: Int J Epidemiol Date: 2012-10 Impact factor: 7.196
Authors: André Lin Ouédraogo; Sake J de Vlas; Issa Nébié; Edith Ilboudo-Sanogo; J Teun Bousema; Aboubakar S Ouattara; Jan Peter Verhave; Nadine Cuzin-Ouattara; Robert W Sauerwein Journal: Acta Trop Date: 2007-09-21 Impact factor: 3.112
Authors: Matthew Cairns; Arantxa Roca-Feltrer; Tini Garske; Anne L Wilson; Diadier Diallo; Paul J Milligan; Azra C Ghani; Brian M Greenwood Journal: Nat Commun Date: 2012-06-06 Impact factor: 14.919
Authors: Aniset Kamanga; Silvia Renn; Derek Pollard; Daniel J Bridges; Brian Chirwa; Jessie Pinchoff; David A Larsen; Anna M Winters Journal: Malar J Date: 2015-09-17 Impact factor: 2.979
Authors: Obinna O Oleribe; Jenny Momoh; Benjamin Sc Uzochukwu; Francisco Mbofana; Akin Adebiyi; Thomas Barbera; Roger Williams; Simon D Taylor-Robinson Journal: Int J Gen Med Date: 2019-11-06
Authors: Issaka Zongo; Paul Milligan; Yves Daniel Compaore; A Fabrice Some; Brian Greenwood; Joel Tarning; Philip J Rosenthal; Colin Sutherland; Francois Nosten; Jean-Bosco Ouedraogo Journal: Antimicrob Agents Chemother Date: 2015-04-27 Impact factor: 5.191